Skip to main content
. 2017 Mar 15;2017(3):CD012600. doi: 10.1002/14651858.CD012600

Cicero 2004a.

Clinical features and settings High‐risk referral for invasive testing
Participants 970 fetuses (20 twin and 1 triplet pregnancy)
UK
Dates not specified
Pregnant women
Median age 37 years (16‐48 years)
11‐14 weeks' gestation (median 12 weeks)
Study design Prospective cohort study
Target condition and reference standard(s) Down's syndrome: 88 cases
Reference standard: CVS
Index and comparator tests Maxillary bone length
Mid‐saggital view of fetal profile obtained for nasal bone. Transducer angled laterally so that the maxillary bone and mandible including the ramus and condylar process can be seen. Maxillary length measured with callipers. Magnified to 0.1 mm increment
Follow‐up 100% karyotyping
Aim of study To determine the value of measuring maxillary length at 11‐14 weeks' gestation in screening for trisomy 21
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Selective testing of high‐risk women as done in practice 
Acceptable reference standard? 
 All tests Yes CVS
Partial verification avoided? 
 All tests Yes All women had a reference standard
Differential verification avoided? 
 All tests Yes All women had the same reference standard
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice 
Uninterpretable results reported? 
 All tests Yes Study reports that measurements were made successfully in all cases
Withdrawals explained? 
 All tests No No details of withdrawals given